Feed Preview

RNA & Tau in Frontotemporal Dementia

RNA & Tau in Frontotemporal Dementia diagram by ibreakstock, Shutterstock
ibreakstock, Shutterstock

Tau mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (ftdp-17) are associated with changes in alternative RNA splicing. Here is the latest research on RNA & Tau in Frontotemporal Dementia.

Top 20 most recent papers
The Journal of Clinical Psychiatry

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

The Journal of Clinical PsychiatryApril 3, 2020
Emily A FerencziKirk R Daffner
Brain : a Journal of Neurology

Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum

Brain : a Journal of NeurologyMarch 18, 2020
W Richard Bevan-JonesJames B Rowe
72
27
Frontiers in Neuroscience

The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Frontiers in NeuroscienceMarch 3, 2020
Yevgeniya A AbramzonRuth Chia
14
1
Journal of Alzheimer's Disease : JAD

Apolipoprotein E Facilitates Amyloid-β Oligomer-Induced Tau Phosphorylation

Journal of Alzheimer's Disease : JADFebruary 18, 2020
Ting-Ting HouYi-Feng Du
2
1
Nature Reviews. Neurology

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

Nature Reviews. NeurologyMarch 24, 2020
Francesco PanzaBruno P Imbimbo
25
Molecular Neurodegeneration

Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD

Molecular NeurodegenerationFebruary 26, 2020
Nadja S AndradeZane Zeier
6
1
Journal of Virology

Amyloid-β and p-Tau Anti-Threat Response to HSV-1 Infection in Primary Adult Murine Hippocampal Neurons

Journal of VirologyFebruary 21, 2020
Rebecca D Powell-DohertyAndrea S Bertke
1
bioRxiv

Integrated analysis of the aging brain transcriptome and proteome in tauopathy

bioRxivFebruary 20, 2020
Carl Grant MangleburgJoshua M Shulman
17
2
1
Movement Disorders : Official Journal of the Movement Disorder Society

Prodromal Dementia with Lewy Bodies: Clinical Characterization and Predictors of Progression

Movement Disorders : Official Journal of the Movement Disorder SocietyFebruary 13, 2020
Marleen van de BeekAfina W Lemstra
14
1
Pharmacological Research : the Official Journal of the Italian Pharmacological Society

Brain microRNAs dysregulation: implication for missplicing and abnormal post-translational modifications of tau protein in Alzheimer's disease and related tauopathies

Pharmacological Research : the Official Journal of the Italian Pharmacological SocietyMarch 4, 2020
Maryam BazrgarAbolhassan Ahmadiani
2
1
NeuroImage. Clinical

Basal forebrain atrophy in frontotemporal dementia

NeuroImage. ClinicalMarch 7, 2020
Rhian S ConveryMartina Bocchetta
2
1
The EMBO Journal

Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD

The EMBO JournalMarch 17, 2020
Bahram KhosraviDieter Edbauer
18
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/rna-tau-in-frontotemporal-dementia/4cf30e99-0a37-471e-951c-2b8a7185a8f6